Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-19

FDA Approved: RANOLAZINE — Original Application (Viona Pharmaceuticals Inc)

View source ↗

Summary

FDA approves a generic version of ranolazine from Viona Pharmaceuticals Inc under an Original ANDA (ANDA210188).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

ORIG AP for RANOLAZINE (RANOLAZINE)